- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/73 - CD4
Détention brevets de la classe C07K 14/73
Brevets de cette classe: 298
Historique des publications depuis 10 ans
|
11
|
16
|
22
|
22
|
48
|
33
|
37
|
32
|
31
|
19
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4303 |
26 |
| City of Hope | 996 |
18 |
| Mcmaster University | 806 |
16 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2861 |
11 |
| Immatics Biotechnologies GmbH | 1156 |
8 |
| Memorial Sloan-Kettering Cancer Center | 1937 |
7 |
| The Trustees of the University of Pennsylvania | 4328 |
5 |
| University of Florida Research Foundation, Inc. | 4035 |
4 |
| Juno Therapeutics, Inc. | 416 |
4 |
| Shattuck Labs, Inc. | 122 |
4 |
| The Board of Trustees of the Leland Stanford Junior University | 6441 |
3 |
| Board of Regents, The University of Texas System | 5828 |
3 |
| The Johns Hopkins University | 5689 |
3 |
| Children's National Medical Center | 272 |
3 |
| The Council of the Queensland Institute of Medical Research | 157 |
3 |
| eFFECTOR Therapeutics, Inc. | 69 |
3 |
| International AIDS Vaccine Initiative | 90 |
3 |
| Seattle Children's Hospital (dba Seattle Children's Research Institute) | 182 |
3 |
| Lentigen Technology, Inc. | 100 |
3 |
| 2seventy bio, Inc. | 76 |
3 |
| Autres propriétaires | 165 |